key: cord-0294667-u2tqf9ap authors: Zheng, H. B.; Doran, B. A.; Kimler, K.; Yu, A.; Tkachev, V.; Niederlova, V.; Cribbin, K.; Fleming, R.; Bratrude, B.; Betz, K.; Cagnin, L.; McGuckin, C.; Keskula, P.; Albanese, A.; Sacta, M.; de Sousa Casal, J.; Taliaferro, F.; Ford, M.; Ambartsumyan, L.; Suskind, D. L.; Lee, D.; Deutsch, G.; Deng, X.; Collen, L. V.; Mitsialis, V.; Snapper, S. B.; Wahbeh, G.; Shalek, A. K.; Ordovas-Montanes, J.; Kean, L. S. title: A Treatment-Naive Cellular Atlas of Pediatric Crohn's Disease Predicts Disease Severity and Therapeutic Response date: 2021-09-22 journal: nan DOI: 10.1101/2021.09.17.21263540 sha: d78dc39a56df9e9d46c77e35022d42d9c9efa8a2 doc_id: 294667 cord_uid: u2tqf9ap Crohn's disease is an inflammatory bowel disease (IBD) which most often presents with patchy lesions in the terminal ileum and colon and requires complex clinical care. Recent advances in the targeting of cytokines and leukocyte migration have greatly advanced treatment options, but most patients still relapse and inevitably progress. Although single-cell approaches are transforming our ability to understand the barrier tissue biology of inflammatory disease, comprehensive single-cell RNA-sequencing (scRNA-seq) atlases of IBD to date have largely sampled pre-treated patients with established disease. This has limited our understanding of which cell types, subsets, and states at diagnosis are predictive of disease severity and response to treatment. Here, through a combined clinical, flow cytometric, and scRNA-seq study, we profile diagnostic human biopsies from the terminal ileum of treatment-naive pediatric patients with Crohn's disease (pediCD; n=14) and from non-inflamed pediatric controls with functional gastrointestinal disorders (FGID; n=13). To fully resolve and annotate epithelial, stromal, and immune cell states among the 201,883 single-cell transcriptomes, we develop and deploy a principled and unbiased tiered clustering approach, ARBOL, yielding 138 FGID and 305 pediCD end cell clusters. Notably, through both flow cytometry and scRNA-seq, we observe that at the level of broad cell types, treatment-naive pediCD is not readily distinguishable from FGID in cellular composition. However, by integrating high-resolution scRNA-seq analysis, we identify significant differences in cell states that arise during pediCD relative to FGID. Furthermore, by closely linking our scRNA-seq analysis with clinical meta-data, we resolve a vector of lymphoid, myeloid, and epithelial cell states in treatment-naive samples which can distinguish patients with less severe disease (those not on anti-TNF therapies (NOA)), from those with more severe disease at presentation who require anti-TNF therapies. Moreover, this vector was also able to distinguish those patients that achieve a full response (FR) to anti-TNF blockade from those more treatment-resistant patients who only achieve a partial response (PR). Our study jointly leverages a treatment-naive cohort, high-resolution principled scRNA-seq data analysis, and clinical outcomes to understand which baseline cell states may predict inflammatory disease trajectory. Inflammatory bowel diseases (IBDs) arise when homeostatic mechanisms regulating 2 gastrointestinal (GI) tract tissue integrity, nutrient absorption, and protective immunity are 3 replaced by pathogenic inflammation (Baumgart and Sandborn, 2012; Chang, 2020; Corridoni et 4 al., 2020a; Friedrich et al., 2019; Graham and Xavier, 2020; Selin et al., 2021) . The initiating 5 triggers are not fully known, but host genetics and the microbiome are being increasingly 6 appreciated to play important, and in some cases causal roles in the IBDs (Chang, 2020; Cohen 7 et al., 2019; Franzosa et al., 2019; Jain et al., 2021; Limon et al., 2019) . Though symptoms are 8 widespread and overlapping, the endoscopic inflammation in the IBDs is often anatomically 9 restricted: ulcerative colitis (UC) manifests primarily as an superficial inflammatory response 10 restricted to the colon, while Crohn's disease (CD) presents predominantly in the terminal ileum 11 and the proximal colon, though lesions may develop anywhere along the gastrointestinal tract 12 (Baumgart and Sandborn, 2012; Chang, 2020; Kobayashi et al., 2020; Roda et al., 2020) . Among 13 the IBDs, pediatric-onset Crohn's disease (pediCD) is particularly common (25% of all IBD cases, 14 60-70 % of pediatric IBD) and is a debilitating form due to its early presentation, impact on the 15 terminal ileum and proximal colon, and the lack of disease-specific therapies developed with 16 children in mind (Hyams et al., 1991; Ruemmele et al., 2014; Sýkora et al., 2018; 17 2012; Ye et al., 2020) . In contrast to pediCD, a group of pediatric disorders termed functional 18 gastrointestinal disorders (FGIDs) include GI symptoms but lack laboratory markers, endoscopic 19 findings, and histologic evidence associated with inflammation (Black et al., 2020; Hyams et al., 20 2016; McOmber and Shulman, 2008; Santucci et al., 2020) . FGID thus represents a critical non-21 inflamed control cohort with which to contextualize the inflammation observed in pediCD. The current standard of care for pediCD (as with adult CD) is tailored to the patient's disease 23 location, clinical behavior and severity, though use of prednisone, immunomodulators, as well as 24 biologics including anti-TNF-a monoclonal antibodies, are common (Hyams et al., 1991; 25 Ruemmele et al., 2014; Turner et al., 2012) . While targeting TNF is common across many 26 autoimmune and inflammatory conditions, it is not successful in all patients, and many go on to 27 develop anti-TNF-refractory disease. It is of tremendous importance for the field to precisely 28 understand and characterize for which patients anti-TNF therapy is not necessary, in which 29 patients it may succeed in controlling disease, and which patients will be refractory to treatment. Several ideas based on individual immunogenicity and pharmacokinetics have been proposed to 31 explain TNF-refractory disease, including gender (M>F), low albumin levels, high BMI, and high 32 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 T or B cell) and subsets (CD8αα+ IEL or CD4+ T cell) to those we identified by flow cytometry 199 data but importantly also enabled us to: 1. characterize these major cell types and subsets without 200 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 9 needing to pre-select markers, and 2. gain substantially enhanced resolution into the cell states 201 (i.e. gene expression programs) within these types and subsets. Following library preparation and sequencing, we derived a unified cells-by-genes expression Table 4 ). Within 219 myeloid cells we identified some of the most significantly upregulated genes in pediCD versus 220 FGID to be CXCL9 and CXCL10, canonical IFNγ-stimulated genes, and S100A8 and S100A9 221 which form the biomarker fecal calprotectin (Supplemental Figure 4f) (Leach et al., 2007; Ziegler 222 et al., 2021) . Within epithelial cells we identified that APOA1 and APOA4 were amongst the most 223 significantly downregulated genes, and correspondingly REG1B, SPINK4 and REG4A were 224 amongst the most significantly upregulated indicating tradeoffs between lipid metabolism and host 225 defense (Supplemental Figure 4f ) (Haberman et al., 2014) . In T cells, we noted that the cytotoxic 226 genes GNLY and GZMA were amongst the most significantly upregulated, with almost no genes 227 downregulated (Supplemental Figure 4f ). We then systematically re-clustered each broad cell type, identifying increasing cellular 229 heterogeneity. Given that we detected changes in the frequency of HLA-DR+ 230 macrophages/dendritic cells and pDCs between pediCD and FGID by flow cytometry, we initially 231 focused on the myeloid cell type sub-clustering, containing dendritic cells, macrophages, 232 monocytes, and pDCs (Supplemental Figure 4g) . Working within this analysis paradigm 233 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 revealed that a traditional clustering approach had difficulty identifying the boundaries of clusters, 234 and whether a cluster composed primarily of pediCD rather than FGID cells represented a unique 235 cell subset, or a cell state overlaid onto a core cell subset gene expression program 236 (Supplemental Figure 4g, Methods) . These distinctions would influence whether a comparison 237 would primarily focus on differential expression testing or differential composition testing between 238 the two clinical cohorts. It also raised the possibility that this joint clustering approach, informed 239 by the inclusion of both FGID and pediCD cell types, subsets and states could muddle some of 240 the unique biology of FGID and pediCD. For instance, this analytical approach could lead to hybrid 241 clusters, informed by cells from both FGID and pediCD and correspondingly critical gene-242 reference lists for each cluster, that may not accurately represent disease-specific cell types, 243 subsets, or states. In order to approach this challenge from a more principled direction, we made five key changes 245 to our analytical workflow, which we jointly refer to as ARBOL (https://github.com/jo-m-246 lab/ARBOL): 1. We proceeded to analyze FGID and pediCD samples separately to define 247 corresponding cell type, subset, and state clusters and markers, 2.We implemented an automated 248 ITC approach to optimize the silhouette score at each tier of iterative sub-clustering and stop (Simpson, 1949) . Using this approach, each tier of analysis 255 is typically under-clustered relative to traditional empirical analyses, but the automation proceeds 256 through several more tiers (typically 6 to 7) until stop conditions (e.g. cell numbers and 257 differentially expressed genes; Methods) are met. We then inspected all outputs (182 FGID and 258 425 pediCD clusters) and provided descriptive cell cluster names independently for FGID and 259 pediCD (Supplemental Figures 5b and 6) . We also focused at this stage on flagging putative 260 doublet clusters or clusters where the majority of differentially expressed genes which triggered 261 further clustering consist of known technical confounders in scRNA-seq data (e.g. mitochondrial, 262 ribosomal, and spillover genes from cells with high secretory capacity) yielding a final number of 263 118 FGID and 305 pediCD clusters (Supplemental Figure 5b) . We note this clustering method 264 represents a data-driven approach, though it may not always reflect a cellular program or 265 transcriptional module of known biological significance. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 We then hierarchically clustered all end cell state clusters to generate the final dendrograms for 267 FGID and pediCD, and performed 1 vs. rest within-Tier 1 clusters (i.e. broad cell types) differential 268 expression to provide systematic names for cells based on their cell type classification and two 269 genes (Figures 3 and 4; Methods) . As several cell types contained readily identifiable and 270 meaningful cell subsets, we utilized curation of literature-based markers to provide further 271 guidance within each cell type (Blériot et al., 2020; Cherrier et al., 2018; Dutertre et al., 2019; 272 Guilliams et al., 2018; Robinette and Colonna, 2016) . For example, within Tier 1 T cells, we could . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Using this analytical workflow, we present comprehensive cellular atlases of FGID (Figure 3 ) and 300 pediCD (Figure 4) , nominate cell states associated with disease severity and treatment outcomes 301 in pediCD (Figure 5) , and identify correspondence between the two (Figure 6) . We focus on 302 pediCD, and those cell states which distinguish between disease severity (NOA vs. PRs/FRs) 303 and baseline gene expression differences in anti-TNF treatment response (FRs vs. PRs). Comprehensive atlas of non-inflammatory FGID From 13 FGID patients, we recovered 12 Tier 1 clusters which we display on a t-stochastic Table 11 ; Methods). We present top marker genes for each main Tier 1 318 cluster/cell type, and note that we also provide complete gene lists calculated through Wilcoxon 319 with Bonferroni adjusted p<0.05 for Tier 1 clusters/cell types, subsets, and end cell states ( Figure 320 3e, Supplemental Tables 5-7). As patient identity did not factor into ITC stop conditions, we then patients, but we comment more extensively on clusters with high patient diversity. Within B cells, we identified a strong division between non-cycling and cycling B cells, with those 325 found in the cycling compartment readily identifiable by germinal center markers and further dark 326 zone (AICDA) and light zone (CD83) genes resulting in FG.B/DZ.AICDA.IGKC and 327 FG.B/LZ.CD74.CD83 clusters (Figure 3d ) (Victora et al., 2010) . Within myeloid cells, we identified, and confirmed using extensive inspection of literature curated 329 markers, cell subsets corresponding to monocytes (CD14, FCGR3A, FCN1, S100A8, S100A9, 330 etc.), macrophages (CSF1R, MERTK, MAF, C1QA, etc.), cDC1 (CLEC9A, XCR1, BATF3), cDC2 331 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 13 (FCER1A, CLEC10A, CD1C, IRF4 etc.) , and pDCs (IL3RA, LILRA4, IRF7) (Figure 3d ; 332 Supplemental Table 6 ) (Blériot et al., 2020; Dutertre et al., 2019; Guilliams et al., 2018 Within T cells, we followed a similar approach as utilized for Myeloid cells and identified principal Table 6 ) (Cherrier et al., 2018; 345 Robinette and Colonna, 2016) . We note that the numerical majority of CD4 T cells (Sallusto et al., 1999) . Within epithelial cells, most cells expressed high levels of OLFM4, identifying them as crypt-351 localized cells (Moor et al., 2018) . We readily identified subsets of stem cells (LGR5), proliferating Table 6 ) (Barker et al., 2007; van der Flier and 355 Clevers, 2009 ). Within endothelial cells, we readily identified vascular and lymphatic endothelial cells (LYVE1, 357 PROX1), with the vascular cells able to be further identified as capillaries (CA4) or venular 358 endothelial cells (ACKR1, MADCAM1) (Brulois et al., 2020) . We also identified a subset of cells 359 (FG.Endth/Peri.FRZB.NOTCH3) expressing high levels of FRZB and NOTCH3, which, rather than 360 being arterioles, likely represent arteriole-associated pericytes or smooth muscle cells given the 361 absence of EFNB2, SOX17, BMX, and HEY1, and the presence of ACTA2 and MYL9, as cluster-362 defining genes (Figure 3d , Supplemental Table 6 ) (Travaglini et al., 2020; Whitsett et al., 2019) . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 We highlight that the FG.Endth/Ven.ACKR1.MADCAM1 cluster is characterized by expression of 364 markers for postcapillary venules specialized in leukocyte recruitment (Thiriot et al., 2017) . Within fibroblasts, we identified principal subsets characterized by their structural roles (COL3A1, Table 6) 368 (Buechler et al., 2021; Davidson et al., 2021 (Das et al., 2017; Heesters et al., 2013) . We also identified a separate Tier 1 373 cluster of glial cells characterized by CRYAB and CLU. Intriguingly within the glial cell Tier 1 374 cluster, we then recovered a cell subset expressing FDCSP, CXCL13, and CR2, a key 375 complement receptor which allows for complement-bound antigens to be recycled and presented 376 by follicular dendritic cells (Das et al., 2017; Heesters et al., 2013) . This highlights the power of 377 iterative tiered clustering to recover discrete cell states that may, through the process of traditional 378 clustering, not be fully resolved. Furthermore, the presence of these discrete cell clusters within 379 larger parent cell clusters will alter the gene expression signatures of the higher-level cell types. For example, the FG.Glial/fDC.FDCSP.CXCL13 in the hierarchical cluster tree then assorts within 381 the lymphoid-organizing stromal cells. The mast cells recovered did not further sub-cluster in an automated fashion, and were largely 383 marked by TPSB2 and TPSAB1 (>97%), with minimal CMA1 (<20%) expressing cells, suggesting 384 they are largely classical MC-T cells in FGID intestine (Dwyer et al., 2021) . We identified four Tier 1 clusters for plasma cells, which are characterized by their strong 386 expression of IGH* immunoglobulin heavy-chain genes together with either an IGK* (kappa light 387 chain) or IGL* (lambda light chain) genes (Cyster and Allen, 2019; James et al., 2020) . This 388 resolved IgA IgK plasma cells, IgA IgL plasma cells, IgM plasma cells, and IgG plasma cells. Iterative tiered clustering identified further heterogeneity within all clusters of IgA and IgG plasma 390 cells, though given the 3'-bias of this dataset, we note that a principled investigation of these 391 clusters would ideally use 5' sequencing with targeted VDJ amplification. Together, our treatment-naïve cell atlas from 13 FGID patients captures 138 cell clusters from a 393 non-inflammatory state of pediatric ileum which we annotated and named in a principled fashion. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Comprehensive atlas of pediCD 396 From the 124,054 cells profiled from 14 pediCD patients, we recovered 12 Tier 1 clusters which 397 here we display on a t-SNE plot colored by cluster identity (Figure 4a) . Distinct from FGID, Paneth 398 cells clustered separately at Tier 1, while glial cells were now found within the fibroblast Tier 1 399 cluster. Inspecting each individual patient's contribution to the t-SNE, we noted that all patients 400 contributed to all Tier 1 clusters (Figure 4b; Supplemental Figure 4c , Supplemental Table 13 ). We then proceeded to generate preliminary descriptive names, independently from the FGID 402 atlas, based on inspection of each cluster within each tier, calculate a hierarchically-clustered 403 dendrogram, and provide systematic names for each end cell state within each cell type and Within B cells, we also identified a strong division between non-cycling and cycling B cells, with 413 those found in the cycling compartment readily identifiable by germinal center markers and further 414 dark zone (AICDA) and light zone (CD83) genes, as in FGID (Victora et al., 2010) . Within cells 415 expressing germinal centers markers, a highly-proliferative branch including clusters such as Table 9 ) (Blériot et al., 2020; Dutertre et al., 2019; Guilliams et al., 2018) . We highlight selected cell states including a migratory dendritic cell 428 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint also expressed monocyte markers (S100A8, S100A9), and expressed detectable, but lower levels 434 of MERTK or AXL relative to bona fide macrophages, potentially indicative of the early stages of 435 the trajectory of monocyte-to-macrophage differentiation (Blériot et al., 2020; Dutertre et al., 2019; 436 Guilliams et al., 2018) . We also noted a substantial expansion of clusters characterized by 437 expression of CXCL9, CXCL10, and STAT1, canonical interferon-stimulated genes, observed in 438 clusters such as CD.Mono/Mac.CXCL10.FCN1 (Ziegler et al., 2020 (Ziegler et al., , 2021 . Moreover, we 439 identified a cluster of inflammatory monocytes, CD.Mono.S100A8.S100A9, characterized by both 440 CD14 and FCGR3A expression. Within T cells, we followed a similar approach as utilized for FGID T cells and identified cell Table 9 ) (Cherrier et al., 2018; Robinette and Colonna, 2016) . We note Table 9 ) (Cherrier et al., 2018; Robinette and Colonna, 2016) . One of the specific challenges in 453 distinguishing between T cells and NK cells in scRNA-seq data is that NK cells can express 454 several CD3-complex genes, particularly CD247, as well as detectable aligned reads for TRDC 455 or TRBC1 and TRBC2, and thus lower-resolution clustering approaches or datasets with lower 456 cell numbers may miss these important distinctions (Björklund et al., 2016; Renoux et al., 2015) . NK cell clusters also expressed the highest levels of TYROBP, which encodes DAP12 and 458 mediates signaling downstream from many NK receptors (French et al., 2006; Lanier, 2001; 459 Lanier et al., 1998) . ILC clusters such as CD.ILC.LST1.AREG or CD.ILC.IL22.KIT were 460 characterized by an apparent ILC3 phenotype, with expression of KIT, RORC and IL22, though 461 they also expressed detectable transcripts of GATA3 in the same clusters (Cherrier et al., 2018; 462 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Robinette and Colonna, 2016). We detected several clusters expressing CD4 and lacking Within epithelial cells we identified substantial heterogeneity in CD. Most cells expressed high 468 levels of OLFM4, identifying them as crypt-localized cells (Moor et al., 2018) . We readily identified Table 9 ) (Barker et al., 2007; van der Flier and Clevers, 2009 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Within fibroblasts, we identified principal subsets characterized by their structural roles (COL3A1, Distinct from the FGID atlas, within the pediCD atlas, glial cells clustered within fibroblasts, but 511 were also marked by S100B, PLP1 and SPP1 expression. The mast cells recovered in pediCD did further sub-cluster in an automated fashion, were largely We also identified four Tier 1 clusters for plasma cells, which are characterized by their strong . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 19 528 Clinical variables and cellular variance that associates with pediCD severity 529 As this pediCD atlas was curated from treatment-naïve diagnostic samples, we were able to 530 interrogate the data to test if overall shifts in cellular composition, specific cell states, and/or gene Table 14 ) (Mathew et al., 2020) . We then used the PC1 (13.4% variation "per cell 541 type" and 13.5% variation "per total cells") and PC2 (12.7% variation "per cell type" and 11.8% TNF_NOA_FR_PR status (r=-0.63). PC1-"per cell type" was also strongly correlated with BMI and 554 PC1-"per total cells" (r>-0.7). PC1-"per cell type" was weakly correlated with patient ID and gender 555 (r<0.3). In order to understand if any cell types were predominantly driving associations with clinical 557 disease severity at initial presentation, we then further deconvoluted the overall PCA on 305 end CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We also detected significant decreases in FRs relative to NOAs in certain cell types, particularly Table 15 ). We note that the relative decrease in M cells is in stark contrast to the "ectopic" M-like 602 cells that were detected in adult ulcerative colitis . We next focused on those cell subsets that were significantly changed only between PRs and based on the GBP gene cluster (Ziegler et al., 2020) . CD.Mono.FCN1.S100A4 was characterized 620 by S100A4, S100A6, and FCN1 expression. These two immune clusters were paralleled by (Roncarolo et al., 2018) . Amongst myeloid cells, CD.cDC2.CLEC10A.FCGR2B were decreased, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint We assessed the compositional differences between FRs and PRs and only identified one cell . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint and CD.EC.ADH1C.GSTA1, clustered in a separate branch together and expressed several 661 enzymes responsible for steroid hormone and dopamine biosynthesis (Figure 4d , 5d) (Cima et 662 al., 2004; Magro et al., 2002) . Importantly for the regenerative potential of the epithelium, 663 CD.EpithStem.LINC00176.RPS4Y1 were also defining of the PC2-positive NOA direction. This 664 suggests that multiple collective changes in the composition and/or state of T/NK/ILC cells, 665 myeloid cells, and epithelial cells at diagnosis may help stratify pediCD patients not only by 666 clinically appreciated disease severity but also may influence anti-TNF responsiveness. To determine whether the disease severity gene signature that we discovered in the PREDICT 668 study can be found in other cohorts, we selected the top 92 markers of the 25 cell states 669 associated with disease severity and treatment outcomes (Supplemental Table 17 ) and As we had generated independent cellular atlases for FGID and pediCD to mitigate "discovery" 683 of hybrid cell clusters that may not represent bona fide biological cell states, we next sought to 684 match and identify correspondence between pediCD and FGID cell subsets. As our study 685 progressed, several analytical methods to integrate scRNA-seq emerged which utilize distinct 686 principles to either predict cell type names given reference gene lists or directly integrate two 687 datasets that were collected from distinct perturbations, tissues, or even species (Hao et al., 2021; 688 Hie et al., 2019; Korsunsky et al., 2019; Pliner et al., 2019) . However, many of these methods are 689 benchmarked on broad cell type or subset integration, and thus their applicability for fine cell 690 states, as in the end clusters we identify here, remains unknown. Thus, we employed a random 691 forest (RF) classifier-based approach, which has recently also been applied successfully in work 692 to identify correspondence in fine sub-clusters in the mammalian retina (Peng et al., 2019; 693 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint Shekhar et al., 2016) . Specifically, we employed paired RF models (one trained on FGID the other 694 trained on pediCD) to obtain cross dataset predictions per cell. We trained these models in scikit-695 learn with 5-fold cross validation and params: min_samples_leaf=1, oob_score=True, 696 criterion="gini", max_depth=200, n_estimators=700, max_features="sqrt" (Pedregosa et al., 697 2011). The training set (but not the test set) was sampled with replacement such that all classes 698 contained as many samples as the maximum proportioned class. This up-sampling procedure 699 provided the largest gain to our test accuracy, sensitivity, and specificity scores, increasing Comparing across myeloid cells between pediCD and FGID, we could identify strong 708 correspondence of specific cell subsets such as cDC1s or pDCs (Figure 6a) . We also identified 709 strong correspondence between several cDC2 clusters. We identified a gradient of monocyte and For T/NK/ILC cells, we identified more discrete patterns relative to Myeloid cells based on 719 comparison of the RF result. Within the two FGID cytotoxic T cell clusters, we identified 720 correspondence by 18 pediCD clusters, representing ILC3s, and cytotoxic NK cells and T cells 721 (Supplemental Figure 8) . The cluster of naïve T cells in FGID had correspondence with the 722 majority of pediCD non-cytotoxic T cell clusters, illustrating a substantial activation and 723 specialization to several discrete T cell states that were specific for pediCD. Importantly, when we jointly clustered macrophages from FGID and pediCD together, we 725 identified that several of the original end clusters identified through ARBOL in pediCD were 726 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In order to provide tissue-scale context and understand the impact on other cell types for these 789 anti-TNF response associated lymphocyte states, we assessed the relationship of these 790 proliferating T and NK cell clusters with epithelial and myeloid cells (Supplemental Figure 8c ). We found that CD.T.MKI67.FOXP3 were strongly positively associated with 792 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The availability of comprehensive clinical, flow cytometric and scRNA-seq data from patients with 822 pediCD and from uninflamed FGID controls created an unprecedented opportunity for 823 comparative atlas creation. We took the opportunity to develop a methodical, unbiased, approach 824 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint 28 to cell state discovery, ARBOL, released alongside our manuscript (https://github.com/jo-m-825 lab/ARBOL). ARBOL iteratively explores axes of variation in scRNA-seq data by clustering and 826 subclustering until variation between cells becomes noise. The philosophy of ARBOL is that every 827 axis of variation could be biologically meaningful so each should be explored, and that axes of lab.github.io/ARBOL/ARBOLtutorial.html), we found the resulting binary tree assorted end 841 clusters into appreciated cell types and subsets (Figures 3 and 4) , and also reveals further 842 previously unappreciated granularity that will serve as the foundation for future work into the 843 cellular composition of the gastrointestinal tract. One of the primary remaining challenges going forward will be to identify which clusters are truly 845 patient-unique, or are simply patient-unique at the cohort size to which we are currently limited to. We calculate a diversity metric for each end cluster to highlight those which are largely conserved 847 between patients, and provide complete cluster-defining gene lists for both FGID and pediCD at 848 three levels of clustering. We also provide links to our data visualization portal to enable cross-849 atlas comparisons: https://singlecell.broadinstitute.org/single_cell/study/SCP1422/predict-2021-850 paper-fgid and https://singlecell.broadinstitute.org/single_cell/study/SCP1423/predict-2021-851 paper-cd. One of the chief advantages of enrolling pediCD patients at diagnosis, and prior to any therapeutic 853 intervention, was that we were able to relate their diagnostic immune landscape with disease 854 trajectory. In the pediCD group, we identified 3 clinical subgroups. The first distinction was made 855 by treating physicians, and classified patients with milder versus more severe clinical disease 856 characteristics at diagnosis. The milder patients were not placed on anti-TNF agents (NOA), while 857 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We noted significant cell state changes at diagnosis underlying clinically-appreciated disease 872 severity that impacted the clinical decision to treat or not to treat with anti-TNF agents. These (Banerjee et al., 2020; von Moltke et al., 2016; Sido et al., 1998) . That pediCD severity is 886 not uniquely predicted by a singular cell subset or gene is reflective of the complex genetics and 887 environmental factors that have been implicated, along with the rich literature that has found 888 significant changes by histology, flow cytometry, or mass cytometry in CD relative to control 889 tissue (Buisine et al., 2001; Leeb et al., 2003; Leonard et al., 1995; Lilja et al., 2000; Mitsialis et 890 al., 2020; Müller et al., 1998; Souza et al., 1999; Stappenbeck and McGovern, 2017; Takayama . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint predicted a later escalation of one of our patients (p022; who appeared as an outlier FR in Figure 895 5d) from FR to PR, which occurred after our database lock in December of 2020. When considering the relationships between T cells and NK cells along with epithelial cells, we 897 captured that proliferating cytotoxic NK cell subsets like CD.NK.MKI67.GZMA were significantly 898 negatively correlated with critical metabolic and progenitor epithelial cell subsets in pediCD. Conversely, proliferating regulatory CD.T.MKI67.FOXP3 were positively associated with 900 secretory epithelial cells in pediCD, but did not appear related to the decrease in metabolic or 901 progenitor cells. How T cell-derived cytokines impact intestinal regeneration and differentiation 902 has recently been the focus of several studies, but the relationship of these fine-grained T cell 903 subsets with specific epithelial cell states observed in the human intestine remained unknown 904 (Biton et al., 2018; Lindemans et al., 2015) . Our work suggests that in the context of the ileum 905 impacted by CD that there is further complexity to understand, particularly as it pertains to 906 cytotoxic NK cells and T cells and their impact on epithelial cell homeostasis and regeneration. The mapping of these disease severity-associated cell networks identifies a host of new potential 908 therapeutic targets for pediCD, for many of which there are clinical-stage therapeutics that could 909 be investigated. These include CD40L-blocking antibodies, IL-22 agonists, and targeted anti-910 proliferation agents (Betts et al., 2017; Lindemans et al., 2015; Miura et al., 2021; Ramanujam et 911 al., 2020; Sootome et al., 2020) .. A case can also be built for targeting inflammatory cytokines 912 such as IL-1, and for interrogating agents aimed at mucosal healing including new anti-GM-CSF 913 antibodies, given that several prominent cell subsets marked by CSF2 were enriched in the PR 914 patients (Ai et al., 2021; Aschenbrenner et al., 2021; Castro-Dopico et al., 2020; Mehta et al., 915 2020; Mitsialis et al., 2020; Muro and Mrowiec, 2015) . This atlas therefore provides a rigorous Recent work on COVID-19 has also highlighted the challenges faced by systems approaches to 920 capture baseline cell states that predict disease trajectory (Kaczorowski et al., 2017; Lucas et al., . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint (Dovrolis et al., 2020; Rajca et al., 2014; Yilmaz et al., 937 2019). We also are limited in our ability to capture spatial information and context from our cohort. It will also be critical to understand how disease progresses and the reason for persistent NOA, 939 FR, or PR patient states in some individuals which will require retention in the trial and repeat 940 possibility of for-cause biopsy procurement. Furthermore, our cohort is representative of the 941 demographics of FGID and IBD in Seattle, WA. It will be essential to understand how both FGID 942 and IBD may present differently across the world, and multiple cohorts will be required to 943 understand location-unique and generalizable findings. We also recognized the number of 944 pediCD patients within this cohort limits our ability to subdivide CD phenotype into location and 945 behavior of disease (via the Paris/Montreal classification systems) (Levine et al., 2011) . Based 946 on this study, we will seek to expand our efforts to validate and extend our findings. We thank the patients and their families for helping and contributing to our study. We thank Kathy . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Patients diagnosed with other inflammatory or infectious etiologies on endoscopy and biopsy were 1082 excluded from the analysis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint (PCDAI), and disease location and phenotype using the Montreal Criteria (Hyams et al., 1991; 1089 Silverberg et al., 2005) . Laboratory evaluation included C-reactive protein, ESR, hemoglobin, 1090 albumin, white blood cell count, and platelet count. Single-cell suspensions were collected from intestinal biopsies using a modified version of a 1113 previously published protocol (Persson et al., 2013) as described in . One 1114 biopsy from the terminal ileum was received directly in hand and processed with an average time 1115 from patient to loading on the 10X Chromium platform of 2.5 total hours, and never exceeding 3.5 1116 hours. While intact, biopsy bites were handled using a P1000 pipette applying gentle suction, and 1117 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Post filtering, we merged sample matrices using an outer join to create an FGID dataset ( We found several disadvantages to this approach. First, we found it difficult to determine for each 1232 cluster whether we should be looking for changes in compositional frequency or gene expression. Particularly within the myeloid major cell group we would find extremely disease biased sub-1234 clusters, as much as a 9:1 ratio between pediCD to FGID. It was unclear whether there was 1235 massive compositional shift within a conserved cell state or if instead a base cell state was split 1236 into multiple clusters based on phenotypic differences in disease and we should perform a 1237 differential expression test between it and neighboring FGID biased clusters. Second, after two 1238 rounds of manual processing we were still unsure if we had reached a base level with each end 1239 cluster corresponding to a unique and biologically homogeneous cell state. Third, at that point, 1240 having partitioned over 100 distinct clusters, individually supervising each subsets processing and 1241 sub-clustering was infeasible. We needed a more systematic method to address these 1242 challenges. It is common to organize cell identity ontologies in a tree structure. With major groups such as 1246 immune, stromal, and epithelial at the top and branching down a level, you might set more 1247 nuanced identities like T, B, endothelial and goblet cell types as a second tier, and even more 1248 nuanced identities like CD4+ vs CD8+ T cells as a third. In ideal circumstances, this mental model 1249 conforms well to RNA-seq data where we can layer gene modules with more and more specific 1250 variation together to describe highly particular cell identities and states. And, by clustering at a 1251 high level with genes that vary across the entire dataset, then sub-clustering with genes that vary 1252 only within a particular parent cluster we are able reveal this hierarchy of cell identity. Many 1253 additional factors to cell identity contribute to the variation in gene expression within actual 1254 datasets, particularly as we found with disease condition during our first approach. To be able to choose the appropriate future analyses and comparisons, we need a highly accurate 1257 representation of cell identity and state. The underlying issue in our first pass at clustering was 1258 that in combining the disease conditions together, the variable genes selected at each stage 1259 represented a combination of differences between cell identity & disease. This combination could 1260 have been manageable if either disease or cell identity were consistently more variable. We could 1261 isolate one factor at a specific tier in the hierarchy before sub-clustering to isolate the other. In . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint our case, disease and cell identity both had many overlapping scales of variation. To address this 1263 problem, we isolated cell identity by separating our dataset by disease and clustering for cell 1264 identity within each disease set (FGID 115, 569 cells, pediCD 139, 342 cells) . This approach did 1265 then require us to perform an additional stage of analysis to find corresponding clusters between 1266 the two datasets, but allowed us to far more effectively distinguish type, scale, and specificity of 1267 disease differences. Within each disease set we still needed a method to ensure we were reaching the bottom level of 1270 biological heterogeneity, and preferably an automated method as our first pass had shown the 1271 potential for isolating hundreds of cell states. To efficiently cluster and isolate these cell states we 1272 wrote a cloud-based pipeline to systematically optimize parameter selection and stop when 1273 biological heterogeneity is exhausted. Homogenous cell subsets were isolated by recursively 1274 normalizing, selecting variable genes, and clustering based on silhouette score. We stopped 1275 recursing into sub-clusters once we reached one of four end conditions defined as: 1276 1277 1. Having a group of less than 100 cells (though we did partition many clusters smaller than 1278 100 cells after clustering groups just larger than that cutoff). 1295 1296 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint Parameters depend on the size of the dataset, and thus must be adjusted based on how many 1297 cells are being partitioned for each recursive step. When calculating nearest neighbor graphs, 1298 and clustering we set the K parameter to `ceiling(0.5*sqrt(N))`. We chose the number of principal 1299 components based on the top 15 percentile of calculated improvement of variance explained. For 1300 subsets less than 500 cells we used Jackstraw to calculate significant principal components. If 1301 neither method succeeded, we chose the first two principal components. This only occurred rarely 1302 at late stages where Jackstraw was unable to find significance. We set clustering resolution via a 1303 grid search optimizing for maximum average silhouette score (silhouette measures the ratio of 1304 intra-cluster distance to inter-cluster distance, where a high score means highly distinct clusters). For stages where we were clustering more than 500 cells a randomized subsample of N cells / 1306 10 was used to calculate the average silhouette score. Additionally, at each recursive step we output quality metrics and basic plots, such as 1:rest 1309 differential expression from the optimal partitioning at each stage and UMAP representations 1310 painted by sample metadata (sample ID, cluster number). Our pipeline, saved output as a 1311 directory structure matching the tree discovered by this recursive clustering. This tree represents After running the hierarchical tiered clustering pipeline we manually curated the generated tree of 1324 clusters. Specifically, tree generation was reinitiated for the B Cells within the FGID dataset as it 1325 had stopped at the first tier on two clusters with < 50 genes differentially expressed, however we 1326 could see in this case that there was additional biological stratification based on strong differential . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint among others. This formed a clear divide between non-proliferating and proliferating B Cells, 1331 further validated by a clear separation within the UMAP based on PCA reduced variable genes 1332 within the B cells. We further examined each branching point of the tree to determine its splitting 1333 cause, noting splits based on spillover, doublet, and singular patient effects. Splits at higher tiers 1334 based on doublets often split again allowing us to recover cells that did not have the dual 1335 expression profile. Splits that only had patient splits below (measured by having only clusters of 1336 single patients) were manually marked as end clusters, thereby merging all clusters below that 1337 split. With these manual steps made, we performed pairwise differential expression to ensure 1338 each partitioned subset is distinct from its neighbors. We annotated these final clusters with four methods attempting to balance descriptiveness, ease 1341 of understanding, and ease of name generation: The first method, is generated during the This method of annotation was particularly useful during analysis as we were immediately able to 1351 see how early or late two clusters had split from each other, as well as seeing a number of the 1352 subset defining genes. Unfortunately, as is apparent this method also produces extremely long 1353 names that are difficult to display and to which to refer. It is also a highly manual process, and 1354 difficult to reproduce precisely. To better present our findings and aid others in reproducing our 1355 results, our third method automates this annotation. This method is performed by taking each 1356 major cell type, which in our case matched the tier one splits, and performing 1:rest differential The resulting tree shows from the bottom up the relationships between cell subsets, and allows 1386 cell subsets that were potentially misclassified at a high split in hierarchical tiered clustering to 1387 find their biological neighboring subsets. As previously mentioned within our description of 1388 hierarchical tiered clustering we did not find any end cluster subsets that met our thresholds for 1389 merging. This does not mean that we did not observe shuffling from the initial tiered splits. While 1390 overall there was good agreement between the two methods, we noted subsets jumping between 1391 major cell types as defined by the first splits of our tiered clustering. We identified the majority of 1392 these jumping subsets as doublet clusters by exploring their differential gene results at multiple 1393 levels of the tiered clustering tree. We removed these doublet subsets and others based on . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Separating the data on disease condition into two datasets was important as it allowed us to 1400 isolate the axis of cell identity within each disease and be confident in the homogeneity of each From this trial run we realized that we needed a more automated system to choose genes as the 1414 most significantly differentially expressed genes did not create enough separation between cluster 1415 centers to effectively classify new cells. We chose to use an RF classifier as it allowed us to train 1416 for the optimal selection of genes, required little to no preparation of data, and provided 1417 probabilities of each cell being predicted to each class. These probabilities for each class proved 1418 particularly useful do to our second realization. Because the number of subsets differs between 1419 disease conditions, we cannot make the assumption that there is a one-to-one relationship 1420 between conditions. We also cannot make the assumption that the many-to-one relationships are 1421 unidirectional with one base subset splitting into many states only from FGID toward CD. A single 1422 classifier would not allow us to distinguish between these many types of relationships. However, 1423 we realized that by creating a classifier for both directions (FGID to pediCD & pediCD to FGID) 1424 we could take advantage of the difference in confidence between the two classifications to 1425 discover the direction and type of relationship. In a perfect world of 1-to-1 relationships, we would 1426 expect all cells of subset A in condition X to match with 100% confidence to subset B in condition 1427 Y. In that particular case the summed probability equal 2 and there would be zero difference in 1428 confidence of one classifier to its matching classifier. In our imperfect world we might instead see 1429 90% of cells of subset A in condition X to matching with > 85% confidence to subset B in condition 1430 Y, and only 30% of subset B in condition Y matching with > 85% confidence. From this 1431 discrepancy we can infer that subset A may be a cell state in condition X that is layered on top of 1432 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 48 max confidence of cell membership). These tables also provide confidences to all classes which 1466 is important for understanding the transverse confidence in both directions. It is especially important to understand the many-to-one relationships between disease conditions 1469 and find where a base cell state becomes layered in additional expression profiles, as these are 1489 the human eye we perform a hierarchical clustering using cosine distance and complete linkage 1490 on the prediction confidences and compute an optimal ordering based on the cosine distances 1491 using the "cba" package in R: https://cran.r-project.org/web/packages/cba/index.html. This allows 1492 us to sort subsets on the rows and columns such that subsets that get predicted similarly are next 1493 to each other. From this visualization we are able to easily discern which are the subsets FGID 1494 that split into many phenotypes within pediCD from high correspondence and bias, which subsets 1495 don't change phenotype much at all based on high correspondence and low bias, and which are 1496 the subsets are potentially unique to a disease condition based on very low correspondence and 1497 bias. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Compositional differences are an important metric for understanding the baseline differences that 1501 prognose a patent's response to treatment. We measure these differences with proportional 1502 enrichment of particular cell subsets within each patient, and finding the significantly reproducible 1503 enrichments across disease. As an extreme toy example we might find that subset A cells We input our cells per million score into a two-sample Wilcoxon test in base R, which is equivalent 1518 to the Mann-Whitney rank score test. We set a significance threshold of p_value < 0.05. We made 1519 5 different pairwise comparisons (FGID vs FR, FGID vs PR, NOA vs FR, NOA vs PR, FR vs PR) . Comparisons between FGID and pediCD groups were determined by finding maximum 1521 correspondence between the disease conditions for each subset. A similar compositional analysis to that done with the Mann-Whitney was performed with a 1525 Fisher's Exact test. Do the difference of the tests we input for each subset the number of cells for 1526 that subset against the number of cells not of that subset within the major cell type split on rows 1527 by pairwise comparisons (NOA vs FR, NOA vs PR, FR vs PR). We computed FDR correction of 1528 p_values at major cell type and entire dataset levels and found significance subsets at both levels. But, most interestingly in comparing the two tests we found that the Mann-Whitney discovered as 1530 significant (pval < 0.05) the portion of cell subsets with largest effect sizes. Understanding our 1531 limited patient number at these within pediCD comparisons and wanting to only report results . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint 51 specific within the resulting landscape of cells. for our purposes, as we knew we would be 1567 exploring a single cell lineage, and exploring the relationships of cell states within that space, we 1568 required for our dimensional reduction the genes common to that space. We selected genes by 1569 performing differential expression between the major cell type and all other cell types within that 1570 disease. We took the outer union of those genes. Then removed genes from the list found to be 1571 differentially expressed between disease conditions at the major cell type level. From these genes 1572 we performed PCA to 50 principal components and then computed a UMAP reduction to 2 1573 components. This selection process allows the dimensional reduction to find smooth gradients 1574 between cells and provided a common space for cells of multiple disease conditions to exist. There are noted spillover effects within the expression tests. We observe ubiquitous 1601 contamination of genes such as IGHA1, IGHG1 and DEFA5 across all cell types and subsets. These genes are routinely found as enriched within more severe inflammation, beyond even this 1603 dataset. This is a real effect, but less than useful for understanding driving factors within individual 1604 cell subsets. So, we focus on significant differentially expressed genes that also have a high Where appropriate, a Bonferroni or FDR correction was used to account for multiple tests, as 1612 noted in the figure legends or Methods. All statistical tests corresponding to differential gene 1613 expression are described above and completed using R language for Statistical Computing . 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint <0.0001* Hgb (g/dl) 11.2 ± 0.5 13.1 ± 0.5 0.0018* . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Two panels of flow cytometry allowed for relative frequency quantification of 32 cell types and subsets, and 10X 3' v2 single-cell RNA-sequencing (scRNA-seq) captured 254,911 total cells including 118 FGID and 305 pediCD end clusters through an iterative tiered clustering (ITC) approach, ARBOL (see Methods). b. Demographic data, weight, height, and BMI for cohort (see Table 1 and Supplemental Figure 1 . c. Clinical inflammatory laboratory values for cohort (see Table 1 and Supplemental Figure 1 ). d. Representative histopathology of FGID (top) and pediCD (bottom) at 10x (scale bar = 100um) and 40x (scale bar = 20um) magnification. e. Representative treatment history and clinical inflammatory parameters used for determination of NOA, FR and PR status (see Methods, Table 1 , and Supplemental Figure 1 ; ADA: adalimumab, INF: infliximab; MTX: methotrexate; Pred: prednisone; mSCD: modified specific carbohydrate diet; EEN: exclusive enteral nutrition). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. e. Fractional composition of dendritic cells, pDCs, central memory (CM) and effector memory (EM) CD4+ and CD8+ cells from 4 NOA, 5FR, and 5 PR patients. Graphs plotted as in d. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint CXCL14 ADAMDEC1 FABP5 PLVAP TPSAB1 TPSB2 JCHAIN IGHM IGHG1 IGHG3 IGLC2 IGLC3 IGHA1 IGKC MS4A1 VPREB3 CST3 C1QA c. tSNE of each major cell type which was used as input into iterative tiered clustering (ITC e. Dot plot of 2 defining genes for each cell type. Dot size represents fraction of cells expressing the gene, and color intensity represents binned count-based expression level (log(scaled UMI+1)) amongst expressing cells. All cluster defining genes are provided in Supplemental Tables 5 to 7. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint PLVAP SPARCL1 TPSAB1 TPSB2 JCHAIN IGHM IGLC2 IGLC3 IGHA2 IGHA1 IGHG3 IGHG1 C1QB C1QA VPREB3 MS4A1 KLRB1 CCL5 REG3A DEFA5 REG1A 333 244 246 180 233 222 497 476 617 233 85 278 159 122 95 46 58 81 152 133 102 222 128 17 59 192 142 107 42 640 211 122 97 94 208 60 83 81 81 38 178 65 49 20 26 107 13 25 13 34 22 25 33 64 312 126 543 142 75 81 33 92 54 89 59 67 30 58 40 81 71 58 93 53 128 55 30 97 63 280 80 86 491 45 36 49 644 56 138 22 48 64 37 58 216 61 32 26 69 46 51 35 57 68 44 70 368 178 110 55 175 35 79 42 49 137 320 108 1060 325 573 1218 458 239 679 333 765 1418 441 471 1699 902 76 3616 300 305 137 249 191 111 430 180 123 649 55 1609 49 269 366 482 80 1457 62 128 117 53 89 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 e. Dot plot of 2 defining genes for each cell type. Dot size represents fraction of cells expressing the gene, and color intensity represents binned count-based expression level (log(scaled UMI+1)) amongst expressing cells. All cluster defining genes are provided in Supplemental Tables 8 to 10 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint a. Correspondence between cell subsets from FGID-to-pediCD and pediCD-to-FGID. Top left heatmaps: RF probabilities for each cell averaged over subset to gain probability of each FGID matching onto each pediCD subset (left), and pediCD onto FGID (right). Bubble plot (center): size = sum(probability matrices) for confidence of predictions, marker color = diff(probability matrices) to show which direction the RF model is more confident on, e.g. more likely for FGID subset to belong to pediCD subset or pediCD subset to belong to FGID subset. Markers are filtered to show the top 10 th percentile of correspondence. Dendrograms: separated-tiered clustering on prediction probabilities of FGID (blue) and pediCD (red) using complete linkage with correlation distance metric, clusters are cut at height 0.7 (range 0-1). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint e. Permutation test results using Hellinger distance to measure if 2 conditions are sampled from the same distribution (0 = complete overlap, 1 = no overlap). Hellinger distance is computed with sqrt(1 -sum(sqrt(kde1*kde2))) with a KDE estimation for each condition group calculated across 1000 points uniformly distributed across plot area, with bandwidth selected using ks::Hpi() function. Black distribution shows test statistic varying min-dist parameter with 11 evenly spaced values between 0.01 and 1. Vertical line shows test statistic using UMAP parameters [min-dist=0.1, Neighbors=ceiling(sqrt(Ncells)), Npcs=50, nDim=2]. Grey distribution shows results of 11,000 permutations to treatment response group varied across same min-dist umap parameters between 0.01 and 1. All tests are significant beyond a 0.001 threshold. f. Violin plot (left) of ((log(scaledUMI+1)) MKI67 expression split on treatment response group. UMAP (right) of lymphocytes with color intensity displaying MKI67 expression based on ((log(scaledUMI+1)) (right). g. Diversity of lymphocyte clusters in FGID and CD: (top) each dot represents a cell subset, y-axis shows how many patients are included within the subset. (bottom) each dot represents a subset, with y position showing (1-Gini-Simpson's Diversity Index), Subsets below red dashed line set at 0.1 diversity were excluded. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 1. b. Representative gating strategy for Panel 2 focused on non-classical T cells and innate lymphoid cells (NB: Lineage = CD14, CD20, CD11c, CD11b, CD56), for antibodies please see Supplemental Table 1 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Supplemental Figure 3 . Comparison of quality control measures reveals similar sequencing depths and gene capture between FGID and pediCD a. Quality control measures for scRNA-seq of ileal biopsies of 27 patients (13 FGID, 14 pediCD) included in the study. Top two graphs denote total genes (nFeature) and UMIs (nCount) after normalization with SCTransform. Lower graphs denote total genes (nFeature), UMIs (nCount) and mitochondrial read percentage (mt.percentage) of preprocessed 10X 3' v2 single-cell RNA-sequenced samples. Cutoffs for individual samples are represented in Supplemental Table 2 . b. Quality control measures as in a split by cell type. c. Comparison of total genes captured (nFeature, left) and total UMIs (nCount, right) between FGID (blue) and pediCD (red) split by cell type. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint a. UMAPs representing one round of clustering of 197,281 single-cells across FGID and pediCD samples. Traditional clustering performed on disease states together. Colors represent major cell types determined by one round of clustering with Seurat RunUMAP parameters (PCs = 1:50, n.neighbors = 50, min.dist = 1). Cell types were assigned based on significantly upregulated marker genes (Wilcoxon; p.adj<0.05) obtained from comparison of specific cell type versus all other cell types. b. UMAPs as in a colored to highlight FGID (blue) and pediCD (red) cells. c. UMAP as in a colored by Tier 1 ITC clusters performed separately for FGID and pediCD. d. Comparison of cell cluster frequencies between FGID (blue) and pediCD (red). Patient contributions denoted by circles (FGID) and triangles (pediCD). e. Differentially expressed genes across cell type in FGID vs pediCD determined to be significant by Wilcoxon test (logFC>0.25, FDR<0.001). f. Volcano plots for Myeloid, Epithelial, T-cell clusters denoting differentially expressed genes in FGID vs. pediCD. Those in pink are significant by Wilcoxon test; Supplemental Table 4 for full gene lists. g. UMAPs of jointly clustered pediCD and FGID Myeloid cells. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint a. Flowchart depicting iterative tiered clustering (ITC) used for generating FGID and pediCD cellular atlases. After sequencing, cells underwent quality control and a cell by gene expression matrix was derived from the 27 ileal samples. Dimensionality reduction and graph-based clustering were performed using the standard Seurat workflow to annotate cell types. Resulting clusters were then iteratively processed through the same pipeline unless end conditions were met. Each cluster was checked for three end conditions which included: only one cluster remaining, two clusters remaining with no more than 5 up and down regulated genes as determined by Wilcoxon test (logFC > 1.5, FDR < 0.001), and/or less than 100 cells in the cluster. Iterative clustering stopped if any of the three conditions are met. Unlike traditional Seurat clustering, in ITC principal component and clustering resolution parameters are chosen automatically. Stop conditions are built in as parameters to the ITC pipeline, allowing customization to the dataset. b. Cell and cluster numbers after various processing steps tabulated c. Random forest classifier approach for integrating FGID and pediCD datasets. FGID and pediCD datasets were used as training datasets to create random forest predictors used in downstream sub-clustering of cell types and subsets. The opposing dataset was then tested by each algorithm independently to determine correspondence and bias as depicted in Figure 6 and Supplemental Figure 8 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Tiered clustering . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint a. Correspondence between cell subsets from FGID-to-pediCD and pediCD-to-FGID. Top left heatmaps: RF probabilities for each cell averaged over subset to gain probability of each FGID matching onto each pediCD subset (left), and pediCD onto FGID (right). Bubble plot (center): size = sum(probability matrices) for confidence of predictions, marker color = diff(probability matrices) to show which direction the RF model is more confident on, e.g. more likely for FGID subset to belong to pediCD subset or pediCD subset to belong to FGID subset. Markers are filtered to show the top 10 th percentile of correspondence. Dendrograms: separated-tiered clustering on prediction probabilities of FGID (blue) and pediCD (red) using complete linkage with correlation distance metric, clusters are cut at height 0.7 (range 0-1). Heatmap: 1-Gini-Simpson index based on patient diversity, mono-patient clusters (white), full representation (black). Right 3 columns show row-normalized of frequency of NOA, FR, PR representation in each pediCD cell subset. Significant differences (Mann-Whitney, alpha=0.05) are marked, triangle NOA vs. PR and circle NOA vs. FR. b. T cells from the main FGID (n = 29,640 cells) and pediCD (n = 38,031) datasets were integrated using identification of mutual nearest neighbors in a reduced space (reciprocal PCA method) with the STACAS package. UMAP plots show distribution of cells coming from FGID (blue) and pediCD (red) datasets and 11 clusters obtained using Louvain algorithm. Sankey plot shows the contribution of ARBOL clusters to each Louvain cluster in the integrated dataset. c. Spearman rank correlation heatmap of the counts-per-million for each of the top 25 clusters defining PC2 positive (NOA-associated) and PC2 negative (PR-associated) vectors. Correlation is represented by both the intensity and size of the box and those which are FDR < 0.05 have a bounding box . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 FG.Plsma/IgG.IGHGP.IGHG2.2 FG.Plsma/IgA.IGHG4.IGHG3 MKI67.LYZ FG.Mono/cDC2 FG.cDC1.SNX3.IDO1 FG.cDC2.RPL37.RPS12 OLFM4.MT−ND2 Goblet.BPIFB1.AQP5 Goblet.FCGBP.SPINK4 Goblet.FCGBP.CLCA1 Goblet.FCGBP.ITLN1 Goblet.S100P.FCGBP Goblet.FCGBP.HES6 Goblet.ITLN1.CLCA1.1 Goblet.CENPA.UBE2C Goblet.REG4.SPINK4 Goblet.RETNLB.ITLN1 Goblet.TFF1.TPSG1 Goblet.ITLN1.CLCA1 Goblet.S100P.TFF1 Enteroendocrine.NEUROG3.MLN EC.LYZ.OLFM4 FCN1.LYST CD.Mono/cDC2 FCN1.LYST CD.Mono/cDC2 Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis STACAS: Sub-Type Anchor Correction for Alignment in Seurat to integrate single-cell RNA-seq data Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF? Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation Identification of stem cells in small intestine and colon by marker gene Lgr5 Crohn's disease Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function High-Resolution mRNA and Secretome Atlas of Human Enteroendocrine Cells T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation The heterogeneity of human CD127+ innate lymphoid cells revealed by single-cell RNA sequencing Functional gastrointestinal disorders: advances in understanding and management Determinants of Resident Tissue Macrophage Identity and Function A molecular map of murine lymph node blood vascular endothelium at single cell resolution Cross-tissue organization of the fibroblast lineage Mucin gene expression in intestinal epithelial cells in Crohn's disease The single-cell transcriptional landscape of mammalian organogenesis The Role of Laboratory Tests in Crohn's Disease GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation Gammadelta T Cells in Crohn's Disease: A New Player in the Disease Pathogenesis? Journal of Crohn's and Colitis Pathophysiology of Inflammatory Bowel Diseases Innate Lymphoid Cell Development: A T Cell Perspective Intestinal Epithelial Cells Synthesize Glucocorticoids and Regulate T Cell Activation Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies Single-cell atlas of colonic CD8+ T cells in ulcerative colitis B Cell Responses: Cell Interaction Dynamics and Decisions Follicular Dendritic Cell Activation by TLR Ligands Promotes Autoreactive B Cell Responses Fibroblasts as immune regulators in infection, inflammation and cancer 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future Interrogating host immunity to predict treatment response in inflammatory bowel disease The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases The enteric nervous system of the human and mouse colon at a single-cell resolution Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation Single-Cell Sequencing of Developing Human Gut Reveals Transcriptional Links to Childhood Crohn's Disease Stem Cells, Self-Renewal, and Differentiation in the Intestinal Epithelium Gut microbiome structure and metabolic activity in inflammatory bowel disease DAP12 Signaling Directly Augments Proproliferative Cytokine Stimulation of NK Cells during Viral Infections Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease Redefining the IBDs using genome-scale molecular phenotyping Quantitative spatial analysis of haematopoiesis-regulating stromal cells in the bone marrow microenvironment by 3D microscopy Pathway paradigms revealed from the genetics of inflammatory bowel disease Developmental and Functional Heterogeneity of Monocytes Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression Integrated analysis of multimodal single-cell data Endocytosis and Recycling of Immune Complexes by Follicular Dendritic Cells Enhances B Cell Antigen Binding and Activation Efficient integration of heterogeneous single-cell transcriptomes using Scanorama Computational Methods for Single-Cell RNA Sequencing Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways Development and Validation of a Pediatric Crohn's Disease Activity Index Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice Distinct microbial and immune niches of the human colon Continuous immunotypes describe human immune variation and predict diverse responses Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease Ulcerative colitis Fast gene set enrichment analysis Fast, sensitive and accurate integration of single-cell data with Harmony Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study Molecular architecture of the developing mouse brain Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes On guard-activating NK cell receptors Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase Neuroproliferation in the mucosa is a feature of coeliac disease and Crohn's disease Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification Tumor Necrosis Factor-Alpha in Ileal Mast Cells in Patients with Crohn's Disease Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Longitudinal analyses reveal immunological misfiring in severe COVID-19 Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium Impaired Synthesis or Cellular Storage of Norepinephrine, Dopamine, and 5-Hydroxytryptamine in Human Inflammatory Bowel Disease Glutathione is required for intestinal function Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy Intestinal bile acid physiology and pathophysiology Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications RAWGraphs: A Visualisation Platform to Create Open Outputs Pediatric Functional Gastrointestinal Disorders Therapeutic blockade of granulocyte macrophage colonystimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities Evidence for Predominant Involvement of the B-Cell System in the Inflammatory Process in Crohn's Disease Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit Spatial Reconstruction of Single Enterocytes Uncovers Broad Zonation along the Intestinal Villus Axis Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome? Targeting immune cell circuits and trafficking in inflammatory bowel disease Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms Allergic inflammatory memory in human respiratory epithelial progenitor cells Colonic epithelial cell diversity in health and inflammatory bowel disease Scikit-learn: Machine Learning in Python Molecular Classification and Comparative Taxonomics of Foveal and Peripheral Cells in Primate Retina EBI2 mediates B cell segregation between the outer and centre follicle IRF4 Transcription-Factor-Dependent CD103+CD11b+ Dendritic Cells Drive Mucosal T Helper 17 Cell Differentiation Supervised classification enables rapid annotation of cell atlases Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohn's Disease Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis Identification of a Human Natural Killer Cell Lineage-Restricted Progenitor in Fetal and Adult Tissues Crohn's disease The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases Silhouettes: A graphical aid to the interpretation and validation of cluster analysis Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Crohn's Disease Evaluation and Treatment: Clinical Decision Tool New advances in the treatment of paediatric functional abdominal pain disorders Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Immunological networks defining the heterogeneity of inflammatory bowel diseases Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Measurement of Diversity International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted Intra-and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis Aurora A Inhibitor TAS-119 Enhances Antitumor Efficacy of Taxanes In Vitro and In Vivo: Preclinical Studies as Guidance for Clinical Development and Trial Design Expression of lymphocyteendothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease-personalised medicine in its infancy Comprehensive Integration of Single-Cell Data Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19 γδ T cells regulate the intestinal response to nutrient sensing Current global trends in the incidence of pediatric-onset inflammatory bowel disease Imbalance of NKp44+NKp46− and NKp44−NKp46+ Natural Killer Cells in the Intestinal Mucosa of Patients With Crohn's Disease A molecular cell atlas of the human lung from single-cell RNA sequencing Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease Feeling the Burn: Intestinal Epithelial Cells Modify Their Lipid Metabolism in Response to Bacterial Fermentation Products Building and Regenerating the Lung Cell by Cell The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States Microbial network disturbances in relapsing refractory Crohn's disease Molecular Architecture of the Mouse Nervous System SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues ** *** *** * *** * *** * ** * * *** * Patien t.ID . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 a. Dot plot of curated genes related to myeloid biology. Dot size represents fraction of cells expressing the gene, and color intensity represents binned count-based expression level (log(scaled UMI+1)) amongst expressing cells. All cluster defining genes are provided in Supplemental Table 7 and Supplemental Table 10 . Dot size is only plotted if more than 5% of cells are expressing the transcript. Names are descriptive names generated from inspection of ITC output which were then converted to standardized naming scheme as in Methods. b. Dot plot of marker genes related to T/NK/ILC lymphoid biology as in a.. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Cell Cluster Frequency of Parent Cell type (log(Cells per Million+1)) e . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Supplemental Figure 7 . Cell types associated with pediCD severity after PCA analysis a. Cell cluster frequencies of the parent cell type found to be significant by Mann-Whitney U test between selected clusters (see Supplemental Figure 7 for all graphs).b. Cell cluster frequencies of the parent cell type between NOA and FR (as above).c. Cell cluster frequencies of the parent cell type between NOA and PR (as above). d. Cell cluster frequencies of the parent cell type between FR and PR (as above).e. GSEA analysis showing the ranks of 92 PREDICT markers (markers of top 25 cell states associated with disease severity and treatment outcomes) in bulk RNA sequencing of illeal or colonic mucosa of two other treatment-naïve cohorts (pediatric RISK cohort, n = 69, adult E−MTAB−7604 cohort, n = 43) comparing pediCD patients who did or did not respond to anti-TNF therapy. P-value is estimated based on an adaptive multi-level split Monte-Carlo scheme.. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Tasic, B., Yao, Z., Graybuck, L.T., Smith, K.A., Nguyen, T.N., Bertagnolli, D., Goldy, J., Garren, E., Economo, M.N., Viswanathan, S., et al. (2018) . Shared and distinct transcriptomic cell types across neocortical areas. Nature 563, 72-78.Thiriot, A., Perdomo, C., Cheng, G., Novitzky-Basso, I., McArdle, S., Kishimoto, J.K., Barreiro, O., Mazo, I., Triboulet, R., Ley, K., et al. (2017) . Differential DARC/ACKR1 expression distinguishes venular from non-venular endothelial cells in murine tissues. BMC Biology 15, 45.. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.17.21263540 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Ziegler, C.G.K., Miao, V.N., Owings, A.H., Navia, A.W., Tang, Y., Bromley, J.D., Lotfy, P., Sloan, M., Laird, H., Williams, H.B., et al. (2021) . Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell.. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021